“…In a meta‐analysis, 27 studies reported that the prevalence of depression in patients with HF ranges from 9 to 60% (Sohani & Samaan, ). The additional effect of depression on mortality in HF has been demonstrated in many studies over different periods, from 3 months to 3 years (short‐term effect); however, the long‐term effect of depression on clinical outcomes is not well known due to the early high mortality rate associated with HF (Adams et al, ; Gathright, Goldstein, Josephson, & Hughes, ; Graven, Martorella, Gordon, Grant Keltner, & Higgins, ). Frequent hospitalizations, fluid restrictions, long‐term use of medications, and the number of health visits required can negatively impact on quality of life, relationships, and the ability to function in normal life activities and work capacity, leading to depression (Sobral Lacerda, Alves Cirelli, Leite de Barros, & de Lima Lopes, ).…”